Literatur
-
1
Dean J et al.
Integrating partners into erectile dysfunction treatment: improving the sexual experience for the couple.
Int J Clin Pract.
2008;
62
127-133
-
2
Tsimtsiou Z et al.
Predictors of physicians' involvement in addressing sexual health issues.
J Sex Med.
2006;
3
583-588
-
3
Bitzer J, Alder J.
Sexualmedizin für Gynäkologen.
Der Gynäkologe.
2008;
41
49-71
-
4 Kockott G, Fahrner E M (Hrsg.). Sexualstörungen des Mannes. Fortschritte der Psychotherapie.. Göttingen: Hogrefe Verlag; 2000
-
5
Lewis R W et al.
Definitions/epidemiology/risk factors for sexual dysfunction.
J Sex Med.
2010;
7 (4 Pt 2)
1598-1607
-
6
Bower H.
The gender identity disorder in the DSM-IV classification: a critical evaluation.
Aust N Z J Psychiatry.
2001;
35
1-8
-
7
Weitze C, Osburg S.
Transsexualism in Germany: empirical data on epidemiology and application of the German Transsexuals' Act during its first ten years.
Arch Sex Behav.
1996;
25
409-425
-
8
Feldman H A et al.
Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.
J Urol.
1994;
151
54-61
-
9
McVary K T.
Clinical practice. Erectile dysfunction.
N Engl J Med.
2007;
357
2472-2481
-
10
Rosen R C et al.
Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction.
Int J Impot Res.
1999;
11
319-326
-
11
Heidelbaugh J J.
Management of erectile dysfunction.
Am Fam Physician.
2007;
81
305-312
-
12
Kostis J B et al.
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
Am J Cardiol.
2005;
96 (12B)
85M-93M
-
13
Bacon C G et al.
Sexual function in men older than 50 years of age: results from the health professionals follow-up study.
Ann Intern Med.
2003;
139
161-168
-
14
Esposito K et al.
Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial.
JAMA.
2004;
291
2978-2984
-
15
Johannes C B et al.
Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study.
J Urol.
2000;
163
460-403
-
16
Carson C C, Lue T F.
Phosphodiesterase type 5 inhibitors for erectile dysfunction.
BJU Int.
2005;
96
257-280
-
17
Vardi M, Nini A.
Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus.
Cochrane Database Syst Rev.
2007;
(1)
CD002187
-
18
Brant W O, Bella A J, Lue T F.
Treatment options for erectile dysfunction.
Endocrinol Metab Clin North Am.
2007;
36
465-479
-
19
Hong B et al.
A double-blind crossover study evaluating the efficacy of korean red ginseng in patients with erectile dysfunction: a preliminary report.
J Urol.
2002;
168
2070-2073
-
20
Ernst E, Pittler M H.
Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials.
J Urol.
1998;
159
433-436
-
21 Hauch M. Paartherapie bei sexuellen Störungen: Das Hamburger Modell: Konzept und Technik.. Stuttgart: Thieme; 2005
-
22
McMahon C G et al.
An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation.
BJU Int.
2008;
102
338-350
-
23
Waldinger M D, McIntosh J, Schweitzer D H.
A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population.
J Sex Med.
2009;
6
2888-2895
-
24
Waldinger M D et al.
A multinational population survey of intravaginal ejaculation latency time.
J Sex Med.
2005;
2
492-497
-
25
Jannini E A, Lenzi A.
Epidemiology of premature ejaculation.
Curr Opin Urol.
2005;
15
399-403
-
26
Wylie K R, Ralph D.
Premature ejaculation: the current literature.
Curr Opin Urol.
2005;
15
393-398
-
27
Waldinger M D, Hengeveld M W, Zwinderman A H.
Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study.
Br J Urol.
1997;
79
592-595
-
28
McMahon C G et al.
Disorders of orgasm and ejaculation in men.
J Sex Med.
2004;
1
58-65
-
29
Hellstrom W J.
Emerging treatments for premature ejaculation: focus on dapoxetine.
Neuropsychiatr Dis Treat.
2009;
5
37-46
-
30
Sadeghi-Nejad H, Watson R.
Premature ejaculation: current medical treatment and new directions (CME).
J Sex Med.
2008;
5
1037-1050
quiz 1051-1052
-
31
Giuliano F, Clement P.
Serotonin and premature ejaculation: from physiology to patient management.
Eur Urol.
2006;
50
454-466
-
32
Modi N B et al.
Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation.
J Clin Pharmacol.
2006;
46
301-309
-
33
Giuliano F.
5-Hydroxytryptamine in premature ejaculation: opportunities for therapeutic intervention.
Trends Neurosci.
2007;
30
79-84
-
34
Rowland D L, De Gouveia Brazao C A, Koos Slob A.
Effective daily treatment with clomipramine in men with premature ejaculation when 25 mg (as required) is ineffective.
BJU Int.
2001;
87
357-360
-
35
Waldinger M D et al.
Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
J Clin Psychopharmacol.
1998;
18
274-281
-
36
Salem E A et al.
Tramadol HCL has promise in on-demand use to treat premature ejaculation.
J Sex Med.
2008;
5
188-193
-
37
Busato W, Galindo C C.
Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study.
BJU Int.
2004;
93
1018-1021
-
38
Althof S.
The psychology of premature ejaculation: therapies and consequences.
J Sex Med.
2006;
3
324-331
-
39
Morales A.
Developmental status of topical therapies for erectile and ejaculatory dysfunction.
Int J Impot Res.
2000;
12
80-85
Dr. med. Katharina V. Rüther
Universitäts-Frauenklinik
Spitalstraße 21
CH-4031 Basel
Schweiz
Email: kruether@uhbs.de
